Literature DB >> 7615846

Effects of treatment on the histopathology of leprosy.

I A Cree1, G Coghill, A M Subedi, N C Abbot, S R Butlin, P D Samson, J S Beck.   

Abstract

AIMS: To identify the histological changes in leprosy skin lesions over the first few weeks after the start of leprosy treatment and to examine their relationship to reversal reaction.
METHODS: Sequential skin biopsy during treatment with multiple drug therapy. In this study, a series of 28 patients was studied, from whom two or more biopsies were taken at two week intervals. Fourteen patients had paucibacillary leprosy (PBL) and 14 had multibacillary leprosy (MBL).
RESULTS: In most cases, granuloma fraction and bacterial index fell during treatment, the bacterial index being less sensitive than the granuloma fraction. Since the biopsies were fixed in buffered formalin and processed through to paraffin wax, little immunohistochemistry was feasible. However, there was strong evidence of immune activation, with increased expression of HLA-DR in the granulomas of MBL and PBL cases: the epidermis also expressed HLA-DR in several patients. Such changes may reflect gamma IFN production from granuloma lymphocytes. Patients with reversal reaction often showed HLA-DR expression on admission which decreased with corticosteroid treatment.
CONCLUSIONS: The results suggest that activation of cell mediated immunity in leprosy lesions occurs during treatment with multiple drug therapy and may not be restricted to those with clinical evidence of reversal reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615846      PMCID: PMC502545          DOI: 10.1136/jcp.48.4.304

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.

Authors:  L A Collings; N Tidman; L W Poulter
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

2.  Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.

Authors:  G Kaplan; A Nusrat; E N Sarno; C K Job; J McElrath; J A Porto; C F Nathan; Z A Cohn
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

3.  Soluble serum interleukin 2 receptor levels in leprosy patients.

Authors:  K S Tung; E Umland; P Matzner; K Nelson; V Schauf; L Rubin; D Wagner; D Scollard; P Vithayasai; V Vithayasai
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Impairment of vasomotor reflexes in the fingertips of leprosy patients.

Authors:  J S Beck; N C Abbot; P D Samson; C R Butlin; J M Grange; I A Cree; A Forster; F Khan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

5.  Reproducibility of histology in leprosy lesions.

Authors:  I A Cree; T Srinivasan; S A Krishnan; C A Gardiner; J Mehta; C A Fisher; J S Beck
Journal:  Int J Lepr Other Mycobact Dis       Date:  1988-06

6.  The association of pregnancy and leprosy. I. New cases, relapse of cured patients and deterioration in patients on treatment during pregnancy and lactation--results of a prospective study of 154 pregnancies in 147 Ethiopian women.

Authors:  M E Duncan; R Melsom; J M Pearson; D S Ridley
Journal:  Lepr Rev       Date:  1981-09       Impact factor: 0.537

7.  In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.

Authors:  R L Modlin; F M Hofman; P R Meyer; O P Sharma; C R Taylor; T H Rea
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.

Authors:  S D Desai; T J Birdi; N H Antia
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.

Authors:  R B Narayanan; L K Bhutani; A K Sharma; I Nath
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

10.  Blood flow velocity in cutaneous lesions of leprosy.

Authors:  I Agusni; J S Beck; R C Potts; I A Cree; M I Ilias
Journal:  Int J Lepr Other Mycobact Dis       Date:  1988-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.